Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657
- Citation:
- J Clin Oncol vol 30 (26) 3242-3249
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 2
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- L. J. Esserman D. A. Berry A. Demichele L. Carey S. E. Davis M. Buxton C. Hudis J. W. Gray C. Perou C. Yau C. Livasy H. Krontiras L. Montgomery D. Tripathy C. Lehman M. C. Liu O. I. Olopade H. S. Rugo J. T. Carpenter L. Dressler D. Chhieng B. Singh C. Mies J. Rabban Y. Y. Chen D. Giri L. van't Veer N. Hylton
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-150007, CALGB-150012, ACRIN-6657
- Phases:
- N/A
- Keywords: